Assessment of Novel Pneumococcal Conjugate Vaccination Scheduled in UK Infants

NCT02918708 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER_GOV

Sponsor class

Stopped funding channel amended by UK department of health

Conditions

Vaccination
Immunization

Interventions

BIOLOGICAL: Synflorix
BIOLOGICAL: Prevenar13

Sponsor

Public Health England

Collaborators

[object Object]
[object Object]